Showing results (211-220 of 525) with videos related to
Sort By:
Pageof 53
The Journal of Molecular Diagnostics : JMD|October 13, 2019
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer PatientsAndrea J Savio, Shivani Kamdar, Renu Jeyapala, et al.American Journal of Medical Genetics|November 20, 2002
An active ring X and haploinsufficiency of SHOX contribute to short stature, congenital anomalies, and developmental delay in a femaleMary Shago, Michael Sgro, Tony Barozzino, et al.Fetal Diagnosis and Therapy|June 28, 2005
Success rate for culture of fetal postmortem tissue is dependent on the method of pregnancy terminationElizabeth J T Winsor, Rory Windrim, David Chitayat, et al.American Journal of Medical Genetics. Part A|March 13, 2012
Male sex bias in placental dysfunctionAlly Murji, Leslie K Proctor, Andrew D Paterson, et al.BJU International|March 1, 2012
Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancerBimal Bhindi, Greg Trottier, Malik Elharram, et al.The Canadian Journal of Urology|May 5, 2006
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.Clinical Genetics|September 5, 2020
Homozygous GLUL deletion is embryonically viable and leads to glutamine synthetase deficiencyMaian Roifman, Kirsten M Niles, Lauren MacNeil, et al.American Journal of Medical Genetics. Part A|September 6, 2025
Mitochondrial Complex V Deficiency Caused by a Homozygous Splice Variant in ATP5POZainab Al Masseri, Laura Guilder, Michal Inbar-Feigenberg, et al.Journal of Genetic Counseling|June 25, 2011
Personality traits associated with genetic counselor compassion fatigue: the roles of dispositional optimism and locus of controlMarie C Injeyan, Cheryl Shuman, Andrea Shugar, et al.Pharmacogenomics|April 16, 2019
Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behaviorLarissa Waldman, Cheryl Shuman, Iris Cohn, et al.Pageof 53